4.7 Article

Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage

Journal

FREE RADICAL BIOLOGY AND MEDICINE
Volume 173, Issue -, Pages 81-96

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2021.07.025

Keywords

Non-heme iron; Heme; Catalytic iron; Nox4; Hydroxyl radicals; Apoptosis; Ferroptosis; Cellular senescence

Funding

  1. China National Science Foundation [31271551, 81970593]
  2. National Institute of Health [1U54DK104309-01, 2R01DK073462, RFA-DK-16-026]
  3. Kidney Precision Medicine Project

Ask authors/readers for more resources

Iron deficiency is identified as a risk factor for nephrotoxic intrinsic acute kidney injury (iAKI), exacerbating damage by increasing catalytic iron species. Targeting specific iron types may be a strategy to mitigate diverse forms of kidney injury in patients.
Iron deficiency is the most common micronutrient deficiency worldwide. While iron deficiency is known to suppress embryonic organogenesis, its effect on the adult organ in the context of clinically relevant damage has not been considered. Here we report that iron deficiency is a risk factor for nephrotoxic intrinsic acute kidney injury of the nephron (iAKI). Iron deficiency exacerbated cisplatin-induced iAKI by markedly increasing nonheme catalytic iron and Nox4 protein which together catalyze production of hydroxyl radicals followed by protein and DNA oxidation, apoptosis and ferroptosis. Crosstalk between non-heme catalytic iron/Nox4 and downstream oxidative damage generated a mutual amplification cycle that facilitated rapid progression of cisplatin-induced iAKI. Iron deficiency also exacerbated a second model of iAKI, rhabdomyolysis, via increasing catalytic heme-iron. Heme-iron induced lipid peroxidation and DNA oxidation by interacting with Nox4independent mechanisms, promoting p53/p21 activity and cellular senescence. Our data suggests that correcting iron deficiency and/or targeting specific catalytic iron species are strategies to mitigate iAKI in a wide range of patients with diverse forms of kidney injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available